Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

The microscopic lesion scoring in adult male albino Wistar rats unexposed to penconazole (PEN), exposed to it, and exposed to it with N-acetyl-1 cysteine (NAC) coadministration
| NC | NAC | PEN | PEN+NAC | |
|---|---|---|---|---|
| Hepatic lesion scoring | ||||
| HCD | 0 a | 1 b | 4 c | 2 d |
| HCN | 0 a | 1 b | 2 c | 1 b |
| ICB | 0 a | 0 a | 4 b | 1 c |
| Congestion | 0 a | 1 b | 3 c | 1 b |
| Haemorrhage | 0 a | 0 a | 2 b | 0 a |
| Inflammation | 0 a | 0 a | 2 b | 1 c |
| Renal lesion scoring | ||||
| RTD | 0 a | 1 b | 4 c | 2 d |
| RTN | 0 a | 1 b | 4 c | 2 d |
| ICB | 0 a | 0 a | 4 b | 1 c |
| Congestion | 0 a | 1 b | 4 c | 2 d |
| Haemorrhage | 0 a | 0 a | 2 b | 0 a |
| Inflammation | 0 a | 0 a | 4 b | 1 c |
Effects of N-acetyl-1-cysteine (NAC) on liver and kidney function tests in adult male albino Wistar rats exposed to penconazole (PEN)
| Group | AST (U/L) | ALT (U/L) | Creatinine (mg/dL) | Urea (mg/dL) |
|---|---|---|---|---|
| NC | 69.66 ± 1.16# | 24.70 ± 0.82# | 0.72 ± 0.01# | 25.18 ± 0.56 |
| PEN | 114.05 ± 4.79* | 51.35 ± 1.46* | 1.62 ± 0.02* | 57.36 ±0.60* |
| PEN+NAC | 86.20 ± 2.15*# | 38.24 ± 1.55*# | 0.85 ± 0.01# | 38.51 ± 0.45*# |
| NAC | 71.23 ± 1.52# | 27.12 ± 0.67# | 0.68 ± 0.01# | 27.94 ± 0.35# |